Transgene Biotek Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|
| Revenue | 0.12 | 0.10 | 0.70 |
| Operating Expense | 0.17 | 0.14 | 0.46 |
| Net Profit | -0.09 | -0.07 | 0.20 |
| Net Profit Margin | -75 | -70 | 28.57 |
| Earning Per Share | -0.01 | -0.01 | 0.03 |
| EBIDTA | -0.05 | -0.03 | 0.24 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Dec 2024 |
|---|---|
| Revenue | 0.12 |
| Operating Expense | 0.17 |
| Net Profit | -0.09 |
| Net Profit Margin | -75.00 |
| Earning Per Share | -0.01 |
| EBIDTA | -0.05 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 0.23 | 0.06 | 0.09 |
| Operating Expenses Annual | 0.85 | 1.11 | 0.55 |
| Operating Profit Annual | -0.43 | -0.88 | -0.25 |
| Interest Annual | 0.13 | 0.18 | 0.23 |
| Depreciation | 0.09 | 0.09 | 0.18 |
| Net Profit Annual | -0.66 | -6.01 | -10.40 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 0.23 |
| Operating Expenses Annual | 0.85 |
| Operating Profit Annual | -0.43 |
| Interest Annual | 0.13 |
| Depreciation | 0.09 |
| Net Profit Annual | -0.66 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | TBA | 0.02 | 0.01 |
| Cash Flow from Operations | TBA | TBA | 0.10 |
| Cash Flow from Investing | TBA | -0.01 | -0.10 |
| Cash Flow from Financing | TBA | TBA | TBA |
| Cash Flow at the End | 0.01 | TBA | 0.02 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | TBA |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -182.61 | -733.33 | -277.78 |
| PBIT Margin (%) | -221.74 | -8,983.33 | -11,300 |
| PBT Margin (%) | 1,391.30 | 5,500.00 | 37,833.33 |
| Net PROFIT Margin (%) | -286.96 | -10,016.67 | -11,555.56 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -2.87 | TBA | TBA |
| Total Debt / Equity (X) | TBA | TBA | 5.23 |
| Asset Turnover Ratio (%) | 0.01 | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -182.61 |
| PBIT Margin (%) | -221.74 |
| PBT Margin (%) | 1,391.30 |
| Net PROFIT Margin (%) | -286.96 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -2.87 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 8.22 | 8.32 | 13.26 |
| Total Current Assets Annual | 1.10 | 1.04 | 0.69 |
| Non Current Assets Annual | 31.34 | 31.44 | 36.53 |
| Total Shareholders Funds Annual | -6.87 | -6.21 | -0.20 |
| Total Assets Annual | 32.44 | 32.48 | 37.22 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 8.22 |
| Total Current Assets Annual | 1.10 |
| Non Current Assets Annual | 31.34 |
| Total Shareholders Funds Annual | -6.87 |
| Total Assets Annual | 32.44 |
EPS (INR)
Expected
0.00
Reported
-0.01
Surprise
0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
